Discover more from Peter’s Newsletter
More “less bad news” - in the last week, 45 Americans were reported dead (amongst 67 reported to the US from around the world) – “NOBODY WANTS THE STEENKING VACCINES”
US Deaths reported to VAERS rose by “only” 45 to 17,478 (amongst an increase of 67 to 35,219 reported into the US from around the world).
Although Biden has signed a Bill ending the national (pandemic) emergency, bivalent C19 mRNA injections remain under Emergency Use Authorization (EUA), the original monovalent C19 mRNA injections have been withdrawn from EUA.
You might be able to make some sense out of the FDA’s simplified recommendations here:
Deaths and Adverse Events from C19 mRNA Injections
From here and here, there were 45 deaths amongst 1,937 adverse events (US only) reported for the week ended 21 April 2023. This lifts the cumulative number of US deaths reported to VAERS to 17,478 and the number of adverse events to 955,353,. Note there may be multiple adverse events for an individual.
More care can/must now be paid to background adverse events and deaths from non-C19 mRNA “vaccinations” such as those from flu injections and Remdesivir
Additionally medics must now be more vigilant around INTERACTIONS of existing treatment protocols with the C19 mRNA injections – as these were not part of any clinical trials and may have escaped notice over the last two years or so since the roll-out of C19 injections.
A key question is “are symptoms and conditions being caused by the INTERACTION of C19 injections with other treatments?” and another is “if there has been an adverse reaction, do I attribute the adverse event to the C19 injection or the original treatment.
Dr McCullough was out today commenting on a French report on Paxlovid interactions. I have not seen reports of interactions with treatments for diabetes, heart disease, cancer, Alzheimer’s, depression or so on – or whether adverse interactions are reported to VAERS when these treatments are combined with C19 injections.
Adverse events and deaths reported to VAERS in any given week could have occurred days, weeks or months ago.
It is a Federal offence NOT to report an adverse reaction OR A SUSPICION of an adverse reaction to a “vaccine” to VAERS.
Total reports to VAERS from all round the world (including the US) for doses made by US companies reporting to the FDA/CDC, were for another 67 deaths amongst 2,749 adverse events for the week, lifting cumulative reports of death reported in to VAERS from around the world for US injections used, to 35,219 amongst 1,550,099 adverse events.
The CDC/FDA have sub-contracted General Dynamics and Eagle Health Technology to process adverse events.
The latest update for deaths and injuries reported to the European adverse events reporting system maintained by the EMA, EUDRA, to 25 February 2023 is here:
The sum of deaths reported to US VAERS (US only reports) and EU EUDRA now stands at 68,086 amongst 6.27 million adverse event reports.
Not a peep of acknowledgement from the US and EU health authorities on the sheer murderous scale of the tragedy of the roll-out of experimental and toxic C19 mRNA or viral vector injections, merely some lip-service to those injured and the lifting of most recommendations and mandates for those under 75 and healthy in the vast majority of developed countries.
Remember the C19 mRNA injections are still recommended everywhere for the elderly (over 75) and infirm with compromised immune systems, because, supposedly, the immune systems of the elderly and infirm are somehow kicked back into life once injected with instructions to create the toxic spike protein – which has been proven to lower the immune system.
Multiply those numbers above by around 6-8 to imagine the global impact – based on proportionate share that the US+EU has of global doses. Then multiply that by around 20-40 to adjust for the under-reporting factor where those responsible for inflicting death and harm do not report to the vaccine harm reporting systems.
All estimates of US deaths from injections need to be reconciled to the leap in extra deaths since the pre-C19 period of 2015-2019 of +560,000 for each calendar year of 2020, 2021 and 2022 graphically illustrated here:
The US death rate is the red line, the blue is total US deaths – green is US population.
This can be compared to the basis for URF’s of around 40 (range 30-100) in the past here:
With a link to an older “refresher” on URF’s here:
For the US only, assuming an Under-Reporting Factor (URF) of 40, this would represent 700,000 deaths amongst 38.2 million adverse events.
Number of C19 mRNA Injections Shipped and Administered
Over the week, the number of bivalent doses administered since authorization on 31 August 2022, increased by 200,000 to 55.6 million from 55.4 million last week.
The number of tots subject to attempted murder and maiming by their parents increased by the usual 10,000 over the week to almost 2 million since authorization on 18 June 2022 (out of around 22.5 million tots in the US).
The bivalent doses consist of 50% of the now withdrawn original monovalent plus 50% targeted to BA4&BA5 variants – all three of these variants are extinct and have been for months.
Out of another 1.5 million doses shipped around the US last week, just 0.4 million were used. The number of unused doses (disposed of or sitting in US freezers) rose to 304.2 million, almost all of which are obsolete as they target long extinct variants.
Here is a chart of daily doses administered since the roll-out of the injections.
It is safe to say that (almost) no-one in the US wants any more (“steenking”) injections and that profits from upcoming price gouging by Pfizer and Moderna (lifting the price from 20 bucks for the first 100 million Moderna doses to perhaps 130 bucks very soon) will be a percentage of close to zero sales.
The percentage of unused US doses out of those shipped remained at a whopping 31%.
EU doses remain unchanged at 1.449 billion shipped with only 976 million used here. There are a whopping 473 million obsolete and unused doses in the EU, either already destroyed or approaching their “use by” dates. The population of the EU is around 444 million.
70% of the world’s 8 billion people have received at least one dose. This works out an average of 2.4 doses each for the 5.6 billion people (out of 8 billion on the planet) that have received at least one dose.
Unused US plus EU doses total well over three quarters of a billion unused doses (771 million).
Deaths from C19 Disease and Cases of SARS-COV2
From here, US C19 “cases” have averaged around 222,000 a week over the course of 2023 and deaths with C19 present have averaged around 2,303 a week. “Cases” last week for the US rose to around 89,000 and deaths with C19 present were 855 for the last week.
The WHO has not revoked the Public Health Emergency of International Concern (PHEIC – pronounced FAKE). Here is a link to its weekly update:
The WHO overview for 30 March 2023 stated:
“Globally, nearly 3.6 million new cases and over 25 000 deaths were reported in the last 28 days (27 February to 26 March 2023), a decrease of 27% and 39%, respectively, compared to the previous 28 days. Despite this overall downward trend, it is important to note that several countries have recently reported significant increases in cases. As of 26 March 2023, over 761 million confirmed cases and over 6.8 million deaths have been reported globally.”
Enquiring minds might want to know how US politicians can declare the end to the C19 emergency when they did not declare its start and how the CDC will react given it takes its marching orders from the WHO, not Congress or POTUS.
Dominant variants circulating in the US, according to the CDC are here:
The right hand table has the latest estimated circulating variant proportions.
Eyes are on the XBB 1.16 variant, code named “Arcturus”. It has now risen to second in the list with almost 10% of all circulating variants. It is attracting a lot of attention in India, where the Oxford/AstraZeneca viral vector injection has been licensed to the Serum Institute and has an 80% share of injections administered.
The WHO upgraded( it to a Variant of Concern on 21 April 2023.
XBB.1.16 is a recombinant variant from BA.2.10.1 and BA.2.75. It has three additional mutations in the SARS-CoV-2 spike protein (E180V, F486P and K478R) compared with its parent lineage, XBB. It is very similar in profile to XBB.1.5, which currently comprises 85% of U.S. cases and 45% of global cases.
“The thing we’re watching the most is how fast this is doubling in countries that it’s in,” Guest told HuffPost. It’s currently being tracked in 29 countries, including the United States.
“It started in India, and we’re seeing a 500% increase in the past month in the Southeast Asia region that includes India, Indonesia, Thailand, Bangladesh, Nepal, Sri Lanka [and] The Maldives,” Guest said. “We’re seeing cases beginning a fairly steep uptick in the Eastern Mediterranean region as well.” In the U.S., XBB.1.16 is also contributing to a sizeable jump in cases.
“In the United States, we’ve started to notice it increasing over the last month,” said Matthew Binnicker, the director of clinical virology at Mayo Clinic in Rochester, Minnesota.”
As you can see in the CDC chart of circulating variants above, XBB 1.16 represents 10% of circulating variants, so it is taking a much larger slice of a diminishing pool of cases (C19 “cases” have dropped from more than 2,000 a month ago to just 825 last week).
Apparently, there is a higher incidence of “pink eye” with the XBB 1.16 variant compared to others, otherwise, symptoms are the same.
The utility of representing any C19 “cases” and “deaths” in the US is rapidly approaching zero.
Please pay for a subscription or donate a coffee (I drink a lot of coffee) - “God Bless You!” if you can’t or don’t want to contribute. Coffee donations here: https://ko-fi.com/peterhalligan - an annual subscription of 100 bucks is one third less than a $3 coffee a week!